Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Vaccine Group are inviting students in school year 12 to take part in a research project to understand whether immunising teenagers with vaccines against ‘Meningitis B’ could protect them and the rest of the community against these potentially deadly bacteria. This is a national study involving 24 000 year 12 students across the United Kingdom. Teenagers at participating schools are being asked to take part by local research teams involved.

Meningitis is caused by an infection around the surface of the brain. It is rare but can be life-threatening and mostly affects babies, young children and adolescents. An important cause of meningitis is a type of bacteria (or germs) called meningococcus.

For more information, please visit  http://beontheteam.uk/ or http://trials.ovg.ox.ac.uk/trials/be-on-the-team

What is the ‘Be on the TEAM’ study?

  • This study will see if immunising teenagers with MenB vaccines reduces the carriage of meningococcus in teenager’s throats, which could in turn protect the broader community
  • Teenagers who take part will receive 2 doses of a Meningitis B vaccine
  • These are licensed vaccines that teenagers would not otherwise receive, and will reduce their risk of meningitis
  • Participants would have two throat swabs taken 1 year apart
  • There would be three study visits, over 12 to 18 months
  • All visits would be held within participating schools

Which schools are taking part?

The schools listed below are participating within the Thames Valley

  • Cheney School, Oxford
  • The Grange School, Aylesbury
  • Kennet School, Thatcham
  • King Alfred’s Academy, Wantage
  • Matthew Arnold School, Oxford
  • Our Lady’s School, Abingdon
  • Queen Anne’s School, Caversham
  • Tudor Hall School, Banbury
  • Park House School, Newbury
  • Radley College, Abingdon
  • Magdalen College School, Oxford
  • St Bartholomew's School, Newbury
  • Oxford High School, Oxford
  • Headington School, Oxford

Where can I find out more information?

The Oxford Vaccine Group study information booklets contain more information (Information booklet)

If you would like any further information regarding the study please contact the study team on:

Email: mencarriage@ovg.ox.ac.uk

Tel: 01865611400

Many thanks,

The MenB Carriage Team

Oxford Vaccine Group

 

Similar stories

Oxford vaccine researchers talk research and home-schooling on ITV's This Morning

COVID-19 Public Engagement

Professor Katie Ewer (The Jenner Institute) and Dr Maheshi Ramasamy (Oxford Vaccine Group) appeared on ITV's This Morning on Wednesday 6 January to talk about their work developing the ChAdOx1 nCoV-19 coronavirus vaccine, all while juggling the demands of young families and home-schooling.

Oxford vaccine stimulates broad antibody and T cell functions

COVID-19 Publication Research

Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.

Award for OVG's learning games

Awards & Appointments Public Engagement

Learning games explaining the links between typhoid, sewage systems and food hygiene have won the gold prize at the Learning Technologies Awards 2020.

SIMON Says…

Publication Research

Researchers at Oxford Vaccine Group have developed machine learning software to predict the efficacy of flu vaccines, offering huge potential for other vaccine research.

Trial of Oxford COVID-19 vaccine in South Africa begins

COVID-19 Research

Participants in South Africa’s first clinical trial for a vaccine against COVID-19 are to be vaccinated this week.